PAR-2 depletion protects against the development of pulmonary hypertension

被引：0
|
作者：
Wygrecka, Malgorzata
Markart, Philipp [1 ]
Marsh, Leigh M. [2 ]
Dahal, Bhola K. [1 ]
Schermuly, Ralph T. [1 ]
Taube, Christian [3 ]
Meinhardt, Andreas
Ghofrani, Ardeschir [1 ]
Steinhoff, Martin [4 ]
Seeger, Werner [1 ]
Preissner, Klaus T.
Weissmann, Norbert [1 ]
Kwapiszewska, Grazyna [1 ]
机构：
[1] Univ Giessen, Dept Internal Med, Lung Ctr, D-6300 Giessen, Germany
[2] Univ Marburg, Dept Clin Chem, D-3550 Marburg, Germany
[3] Johannes Gutenberg Univ Mainz, Med Clin 3, Mainz, Germany
[4] Univ Calif San Francisco, Dept Dermatol & Surg, San Francisco, CA 94143 USA
来源：
VASCULAR PHARMACOLOGY | 2012年 / 56卷 / 5-6期
关键词：
D O I：
10.1016/j.vph.2011.08.124
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：350 / 350
页数：1
相关论文
共 50 条
  • [21] Isorhynchophylline protects against pulmonary arterial hypertension and suppresses PASMCs proliferation
    Guo, Haipeng
    Zhang, Xin
    Cui, Yugian
    Deng, Wei
    Xu, Dachun
    Han, Hui
    Wang, Hao
    Chen, Yuguo
    Li, Yu
    Wu, Dawei
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2014, 450 (01) : 729 - 734
  • [22] Sertraline protects against monocrotaline-induced pulmonary hypertension in rats
    Li, Xue-Qin
    Hong, Yang
    Wang, Yun
    Zhang, Xin-Hua
    Wang, Huai-Liang
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2006, 33 (11) : 1047 - 1051
  • [23] Isoquercitrin protects against pulmonary hypertension via inhibiting PASMCs proliferation
    Zhang, Yongtao
    Cui, Yuqian
    Deng, Wei
    Wang, Hao
    Qin, Weidong
    Huang, Chengmin
    Li, Chen
    Zhang, Jianning
    Guo, Yuan
    Wu, Dawei
    Guo, Haipeng
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2017, 44 (03): : 362 - 370
  • [24] Par-2 plays a protective role in pancreatitis
    Singh, VP
    Saluja, AK
    Navina, S
    Bhagat, L
    Andrade-Gordon, P
    Steer, ML
    GASTROENTEROLOGY, 2003, 124 (04) : A94 - A95
  • [25] The effects of trypsin on pancreatic PAR-2 receptors
    Hegyi, Péter
    Ozsvári, Béla
    Ignáth, Imre
    Venglovecz, Viktória
    Rakonczay, Zoltán, Jr.
    Takács, Tamás
    Borka, Katalin
    Schaff, Zsuzsa
    Papp, Gyula J.
    Tóth, András
    Varró, Andárs
    Sahin-Tóth, Miklós
    Lonovics, János
    PANCREAS, 2006, 33 (04) : 468 - 469
  • [26] Bringing GERD Management up to PAR-2
    Souza, Rhonda F.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2010, 105 (09): : 1944 - 1946
  • [27] Tryptase as a PAR-2 activator in joint inflammation
    Kelso, E. B.
    Dunning, L.
    Lockhart, J. C.
    FErrell, W. R.
    Plevin, R.
    Sommerhoff, C. P.
    ARTHRITIS RESEARCH & THERAPY, 2005, 7 (Suppl 1) : S38 - S38
  • [28] Preventing Autoimmunity Protects Against the Development of Hypertension and Renal Injury
    Mathis, Keisa W.
    Wallace, Kedra
    Flynn, Elizabeth R.
    Maric-Bilkan, Christine
    LaMarca, Babbette
    Ryan, Michael J.
    HYPERTENSION, 2014, 64 (04) : 792 - +
  • [29] Protease-activated receptor-2 (PAR-2)-related peptides induce tear secretion in rats: Involvement of PAR-2 and non-PAR-2 mechanisms
    Nishikawa, H
    Kawai, K
    Tanaka, M
    Ohtani, H
    Tanaka, S
    Kitagawa, C
    Nishida, M
    Abe, T
    Araki, H
    Kawabata, A
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2005, 312 (01): : 324 - 331
  • [30] Cardiovascular responses mediated by protease-activated receptor-2 (PAR-2) and thrombin receptor (PAR-1) are distinguished in mice deficient in PAR-2 or PAR-1
    Damiano, BP
    Cheung, WM
    Santulli, RJ
    Fung-Leung, WP
    Ngo, K
    Ye, RD
    Darrow, AL
    Derian, CK
    De Garavilla, L
    Andrade-Gordon, P
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1999, 288 (02): : 671 - 678
12345